Fig 1.
PRISMA flow diagram of study selection process.
Table 1.
Study characteristics of case reports and case series studies.
Table 2.
Study characteristics of cohort studies (observational studies & retrospective studies).
Fig 2.
All-cause mortality associated with fungal secondary infections among COVID-19 patients who used AFT.
(A): All-cause mortality associated with AFT and without AFT in fungal secondary infections among COVID-19 patients; (B): All-cause mortality associated with mono- and combination AFT in fungal secondary infections among COVID-19 patients; (C): All-cause mortality associated with duration of AFT in fungal secondary infections among COVID-19 patients; (D): All-cause mortality associated with AFT and without AFT in patients with CAPA and (E): All-cause mortality associated with duration of AFT in patients with CAPA.